Iran vs MENA Programme Region: Percentage of surviving infants who received the third dose of
Iran
98
in 2025
MENA Programme Region
83
in 2025
Iran rank
3rd
MENA Programme Region rank
2nd
Percentage of surviving infants who received the third dose of over time
- Iran
- MENA Programme Region
How they compare
Iran currently reports 98 against 83 in MENA Programme Region, a difference of 15.
That makes Iran's figure about 1.2 times MENA Programme Region's.
Across all 11 years both countries report, Iran has been ahead every year.
Iran ranks 3rd and MENA Programme Region ranks 2nd of 20 countries.
Iran has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran | MENA Programme Region | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8 | 89 | 9.8 | Iran |
| 2020s | 98.5 | 83.33 | 15.17 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of surviving infants who received the third dose of, Iran or MENA Programme Region?
- Iran, at 98 against 83 in MENA Programme Region as of 2025.
- What is the difference in percentage of surviving infants who received the third dose of between Iran and MENA Programme Region?
- 15, with Iran ahead.
- How many years of comparable data are there for Iran and MENA Programme Region?
- 11 years are reported by both, from 2015 to 2025.
- How do Iran and MENA Programme Region rank globally for percentage of surviving infants who received the third dose of?
- Iran ranks 3rd and MENA Programme Region ranks 2nd of 20 countries.
- Where does this data come from?
- UNICEF, published as Percentage of surviving infants who received the third dose of Hib-containing vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.